Search

Acute coronary syndrome (ACS) encompasses a spectrum of clinical entities, ranging from unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI) to ST-elevation myocardial infarction (STEMI). This book analyzes new research on the diagnosis and management of ACS. The first chapter reviews ethnic and gender differences in the diagnosis, risk factors and management of a multiethnic population in Malaysia. Chapter Two summarizes data from available studies conducted over the past last 30 years about pharmacologic reperfusion therapy including comparison with primary angioplasty. Chapter Three discusses the up-to-date available studies that have investigated consent in cardiology.

Acute myocardial infarction (AMI) is a major cause of morbidity and mortality. The almost exclusive cause of acute coronary syndromes (ACS), including unstable angina, AMI with or without ST-segment elevation, and sudden cardiac death is atherothrombosis. This book discusses risk factors, emergency management and long-term health outcomes of myocardial infarctions. Some of the topics discussed include MI and cardiogenic shock; risk of MI in the pathophysiology and treatment of prostatic diseases; albuminuria; essential roles of monocytes/macrophages in ACI; and management of unstable angina/non-ST segment MI.

The Pathophysiology and Pharmacotherapy of Myocardial Infarction deals with the advances in the pathophysiology and pharmacotherapy of acute myocardial infarction and related complications. This book covers two major consequences—cardiac muscle dysfunction and cardiac electrical dysfunction. This text begins by reviewing the controversy surrounding the pathogenetic mechanisms of atheroma formation and its potential reversibility, including the status of coronary risk factors and benefits of primary prevention. The pathophysiologic mechanisms of pump failure and the current approach to its management are then deliberated, followed by a discussion on the rational use of vasodilators in post-infarction heart failure and pharmacotherapy of cardiogenic shock. The rationale for the interest in the role of coronary vasospasm and thrombolytic therapy for acute myocardial infarction is also covered. This publication concludes by reviewing the approaches for the management of post-infarction ventricular tachyarrhythmias and concept of secondary prevention of sudden cardiac death. This compilation is valuable to medical students, primary care physicians, and cardiovascular specialists.